CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Stop Heart Attack Dot Com

Stop Heart Attack Dot Com is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VTI

VTI Corp. is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedFlight of Ohio

MedFlight of Ohio is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genome Medical

Our vision is a world where genomic information is fully accessible, understandable and integrated into health and well being. We are on a mission to help patients and healthcare providers use genetic services to improve health, lower the cost of care, and prevent disease.

Numoda

Numoda is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.